Cargando…

Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up

AIM: To retrospectively evaluate the factors that influence long-term outcomes of duodenal papilla carcinoma (DPC) after standard pancreaticoduodenectomy (SPD). METHODS: This is a single-centre, retrospective study including 112 DPC patients who had a SPD between 2006 and 2015. Associations between...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Pei-Long, Chang, Yuan, Xu, Xiu-Chun, Zhao, Zhen, Wang, Xian-Qiang, Xu, Ke-Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558121/
https://www.ncbi.nlm.nih.gov/pubmed/28852317
http://dx.doi.org/10.3748/wjg.v23.i30.5579
_version_ 1783257341656825856
author Lian, Pei-Long
Chang, Yuan
Xu, Xiu-Chun
Zhao, Zhen
Wang, Xian-Qiang
Xu, Ke-Sen
author_facet Lian, Pei-Long
Chang, Yuan
Xu, Xiu-Chun
Zhao, Zhen
Wang, Xian-Qiang
Xu, Ke-Sen
author_sort Lian, Pei-Long
collection PubMed
description AIM: To retrospectively evaluate the factors that influence long-term outcomes of duodenal papilla carcinoma (DPC) after standard pancreaticoduodenectomy (SPD). METHODS: This is a single-centre, retrospective study including 112 DPC patients who had a SPD between 2006 and 2015. Associations between serum levels of CA19-9 and CEA and various clinical characteristics of 112 patients with DPC were evaluated by the χ(2) test and Fisher’s exact test. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 60 mo (ranging from 4 mo to 168 mo). Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis. The difference in survival curves was evaluated with a log-rank test. RESULTS: In 112 patients undergoing SPD, serum levels of CA19-9 was associated with serum levels of CEA and drainage mode (the P values were 0.000 and 0.033, respectively); While serum levels of CEA was associated with serum levels of CA19-9 and differentiation of the tumour (the P values were 0.000 and 0.033, respectively). The serum levels of CA19-9 and CEA were closely correlated (χ² = 13.277, r = 0.344, P = 0.000). The overall 5-year survival was 50.00% for 112 patients undergoing SPD. The Kaplan-Meier survival analysis showed that increased serum levels of CA19-9, CEA, and total bilirubin were correlated with a poor prognosis, as well as a senior grade of infiltration depth, lymph node metastases, and TNM stage(the P values were 0.033, 0.018, 0.015, 0.000, 0.000 and 0.000, respectively). Only the senior grade of infiltration depth and TNM stage retained their significance when adjustments were made for other known prognostic factors in Cox multivariate analysis (RR = 2.211, P = 0.022 and RR = 2.109, P = 0.047). CONCLUSION: For patients with DPC, the serum levels of CA19-9 and CEA were closely correlated, and play an important role in poor survival. Increased serum levels of total bilirubin and lymph node metastases were also correlated with a poor prognosis. The senior grade of infiltration depth and TNM stage can serve as independent prognosis indexes in the evaluation of patients with DPC after SPD.
format Online
Article
Text
id pubmed-5558121
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55581212017-08-29 Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up Lian, Pei-Long Chang, Yuan Xu, Xiu-Chun Zhao, Zhen Wang, Xian-Qiang Xu, Ke-Sen World J Gastroenterol Retrospective Study AIM: To retrospectively evaluate the factors that influence long-term outcomes of duodenal papilla carcinoma (DPC) after standard pancreaticoduodenectomy (SPD). METHODS: This is a single-centre, retrospective study including 112 DPC patients who had a SPD between 2006 and 2015. Associations between serum levels of CA19-9 and CEA and various clinical characteristics of 112 patients with DPC were evaluated by the χ(2) test and Fisher’s exact test. The patients were followed-up every 3 mo in the first two years and at least every 6 mo afterwards, with a median follow-up of 60 mo (ranging from 4 mo to 168 mo). Survival analysis was conducted using the Kaplan-Meier survival and Cox proportional hazards model analysis. The difference in survival curves was evaluated with a log-rank test. RESULTS: In 112 patients undergoing SPD, serum levels of CA19-9 was associated with serum levels of CEA and drainage mode (the P values were 0.000 and 0.033, respectively); While serum levels of CEA was associated with serum levels of CA19-9 and differentiation of the tumour (the P values were 0.000 and 0.033, respectively). The serum levels of CA19-9 and CEA were closely correlated (χ² = 13.277, r = 0.344, P = 0.000). The overall 5-year survival was 50.00% for 112 patients undergoing SPD. The Kaplan-Meier survival analysis showed that increased serum levels of CA19-9, CEA, and total bilirubin were correlated with a poor prognosis, as well as a senior grade of infiltration depth, lymph node metastases, and TNM stage(the P values were 0.033, 0.018, 0.015, 0.000, 0.000 and 0.000, respectively). Only the senior grade of infiltration depth and TNM stage retained their significance when adjustments were made for other known prognostic factors in Cox multivariate analysis (RR = 2.211, P = 0.022 and RR = 2.109, P = 0.047). CONCLUSION: For patients with DPC, the serum levels of CA19-9 and CEA were closely correlated, and play an important role in poor survival. Increased serum levels of total bilirubin and lymph node metastases were also correlated with a poor prognosis. The senior grade of infiltration depth and TNM stage can serve as independent prognosis indexes in the evaluation of patients with DPC after SPD. Baishideng Publishing Group Inc 2017-08-14 2017-08-14 /pmc/articles/PMC5558121/ /pubmed/28852317 http://dx.doi.org/10.3748/wjg.v23.i30.5579 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Lian, Pei-Long
Chang, Yuan
Xu, Xiu-Chun
Zhao, Zhen
Wang, Xian-Qiang
Xu, Ke-Sen
Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title_full Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title_fullStr Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title_full_unstemmed Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title_short Pancreaticoduodenectomy for duodenal papilla carcinoma: A single-centre 9-year retrospective study of 112 patients with long-term follow-up
title_sort pancreaticoduodenectomy for duodenal papilla carcinoma: a single-centre 9-year retrospective study of 112 patients with long-term follow-up
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558121/
https://www.ncbi.nlm.nih.gov/pubmed/28852317
http://dx.doi.org/10.3748/wjg.v23.i30.5579
work_keys_str_mv AT lianpeilong pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup
AT changyuan pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup
AT xuxiuchun pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup
AT zhaozhen pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup
AT wangxianqiang pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup
AT xukesen pancreaticoduodenectomyforduodenalpapillacarcinomaasinglecentre9yearretrospectivestudyof112patientswithlongtermfollowup